What's Happening?
Jackie Tohn, an actress known for her role in the Netflix series 'Nobody Wants This,' has shared her personal journey with genetic testing, which she credits with saving her life. After her father was diagnosed with metastatic carcinomas and tested positive
for the BRCA1 genetic mutation, Tohn underwent genetic testing herself. The results revealed that she also carried the BRCA1 mutation, significantly increasing her risk for breast and ovarian cancers. Faced with an 85% chance of developing breast cancer, Tohn opted for a preventative double mastectomy. Her story highlights the importance of genetic testing, especially for those with a family history of cancer or specific ethnic backgrounds, such as Ashkenazi Jewish descent. Tohn has partnered with Myriad Genetics to raise awareness about the benefits of genetic testing for hereditary cancer risks.
Why It's Important?
Tohn's experience underscores the critical role of genetic testing in early cancer detection and prevention. For individuals with a family history of cancer, genetic testing can provide crucial information about their health risks, enabling them to make informed decisions about preventative measures. This is particularly significant for those with genetic mutations like BRCA1, which dramatically increase cancer risk. By sharing her story, Tohn aims to encourage others to consider genetic testing, potentially saving lives through early intervention. Her advocacy also highlights the broader public health implications, as increased awareness and access to genetic testing could lead to earlier detection and treatment of hereditary cancers, ultimately reducing cancer-related mortality rates.
What's Next?
Following her surgery, Tohn continues to advocate for genetic testing and cancer awareness. She is actively involved in promoting resources like learnmyrisk.com, where individuals can learn more about their genetic risks and testing options. Tohn's ongoing efforts aim to increase public understanding of hereditary cancer risks and the importance of proactive health measures. As more people become aware of the benefits of genetic testing, healthcare providers may see an increase in demand for these services, potentially leading to advancements in genetic research and testing technologies.
